Microscopic-observation drug-susceptibility assay for the diagnosis of TB
- PMID: 17035648
- PMCID: PMC1780278
- DOI: 10.1056/NEJMoa055524
Microscopic-observation drug-susceptibility assay for the diagnosis of TB
Abstract
Background: New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in proof-of-principle studies of the microscopic-observation drug-susceptibility (MODS) assay, in which broth cultures are examined microscopically to detect characteristic growth.
Methods: In an operational setting in Peru, we investigated the performance of the MODS assay for culture and drug-susceptibility testing in three target groups: unselected patients with suspected tuberculosis, prescreened patients at high risk for tuberculosis or multidrug-resistant tuberculosis, and unselected hospitalized patients infected with the human immunodeficiency virus. We compared the MODS assay head-to-head with two reference methods: automated mycobacterial culture and culture on Löwenstein-Jensen medium with the proportion method.
Results: Of 3760 sputum samples, 401 (10.7%) yielded cultures positive for Mycobacterium tuberculosis. Sensitivity of detection was 97.8% for MODS culture, 89.0% for automated mycobacterial culture, and 84.0% for Löwenstein-Jensen culture (P<0.001); the median time to culture positivity was 7 days, 13 days, and 26 days, respectively (P<0.001), and the median time to the results of susceptibility tests was 7 days, 22 days, and 68 days, respectively. The incremental benefit of a second MODS culture was minimal, particularly in patients at high risk for tuberculosis or multidrug-resistant tuberculosis. Agreement between MODS and the reference standard for susceptibility was 100% for rifampin, 97% for isoniazid, 99% for rifampin and isoniazid (combined results for multidrug resistance), 95% for ethambutol, and 92% for streptomycin (kappa values, 1.0, 0.89, 0.93, 0.71, and 0.72, respectively).
Conclusions: A single MODS culture of a sputum sample offers more rapid and sensitive detection of tuberculosis and multidrug-resistant tuberculosis than the existing gold-standard methods used.
Copyright 2006 Massachusetts Medical Society.
Figures



Comment in
-
Rapid detection of tuberculosis and drug-resistant tuberculosis.N Engl J Med. 2006 Oct 12;355(15):1606-8. doi: 10.1056/NEJMe068173. N Engl J Med. 2006. PMID: 17035655 No abstract available.
-
MODS assay for the diagnosis of TB.N Engl J Med. 2007 Jan 11;356(2):188; author reply 189. doi: 10.1056/NEJMc063088. N Engl J Med. 2007. PMID: 17215539 No abstract available.
-
MODS assay for the diagnosis of TB.N Engl J Med. 2007 Jan 11;356(2):188; author reply 189. N Engl J Med. 2007. PMID: 17225284 No abstract available.
-
Microscopic-observation drug-susceptibility assay was more sensitive than standard tests for diagnosing tuberculosis.ACP J Club. 2007 Mar-Apr;146(2):45. ACP J Club. 2007. PMID: 17335168 No abstract available.
Similar articles
-
Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.Am J Respir Crit Care Med. 2011 May 15;183(10):1427-33. doi: 10.1164/rccm.201009-1449OC. Epub 2011 Feb 4. Am J Respir Crit Care Med. 2011. PMID: 21297071
-
Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.J Clin Microbiol. 2004 Oct;42(10):4432-7. doi: 10.1128/JCM.42.10.4432-4437.2004. J Clin Microbiol. 2004. PMID: 15472289 Free PMC article.
-
Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.J Clin Microbiol. 2007 Apr;45(4):1093-7. doi: 10.1128/JCM.01949-06. Epub 2007 Jan 24. J Clin Microbiol. 2007. PMID: 17251409 Free PMC article.
-
Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.BMC Infect Dis. 2009 May 20;9:67. doi: 10.1186/1471-2334-9-67. BMC Infect Dis. 2009. PMID: 19457256 Free PMC article. Review.
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013359. doi: 10.1002/14651858.CD013359.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Sep 6;9:CD013359. doi: 10.1002/14651858.CD013359.pub3. PMID: 32853411 Free PMC article. Updated.
Cited by
-
Early and efficient detection of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures.PLoS One. 2013;8(2):e57527. doi: 10.1371/journal.pone.0057527. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23469014 Free PMC article.
-
Solar disinfection of MODS mycobacterial cultures in resource-poor settings.PLoS One. 2007 Oct 31;2(10):e1100. doi: 10.1371/journal.pone.0001100. PLoS One. 2007. PMID: 17971863 Free PMC article.
-
Optimizing tuberculosis testing for basic laboratories.Am J Trop Med Hyg. 2010 Oct;83(4):896-901. doi: 10.4269/ajtmh.2010.09-0566. Am J Trop Med Hyg. 2010. PMID: 20889887 Free PMC article.
-
Low-cost 3D-printed inverted microscope to detect Mycobacterium tuberculosis in a MODS culture.Tuberculosis (Edinb). 2022 Jan;132:102158. doi: 10.1016/j.tube.2021.102158. Epub 2021 Nov 30. Tuberculosis (Edinb). 2022. PMID: 34864388 Free PMC article.
-
Alternative methods of diagnosing drug resistance--what can they do for me?J Infect Dis. 2011 Nov 15;204 Suppl 4(Suppl 4):S1110-9. doi: 10.1093/infdis/jir448. J Infect Dis. 2011. PMID: 21996693 Free PMC article. Review.
References
-
- Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization. 2006. [Accessed September 15, 2006]. pp. 1–242. http://www.who.int/tb/publications/global_report/2006/en/index.html.
-
- The global plan to stop TB, 2006–2015 Geneva. Stop TB Partnership and World Health Organization. 2006. [Accessed September 15, 2006]. pp. 1–172. http://www.stoptb.org/globalplan.
-
- Espinal MA, Kim SJ, Suarez PG, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA. 2000;283:2537–45. - PubMed
-
- Chavez Pachas AM, Blank R, Smith Fawzi MC, Bayona J, Becerra MC, Mitnick CD. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru. Int J Tuberc Lung Dis. 2004;8:52–8. - PubMed
-
- Dowdy DW, Chaisson RE, Moulton LH, Dorman SE. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS. 2006;20:751–62. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical